International Pharmaceutical Abstracts

International Pharmaceutical Abstracts

International Pharmaceutical Abstracts (IPA) was introduced by The American Society of Health-System Pharmacists (ASHP) in 1964. Beginning with print production, it was launched electronically in 1970. IPA is published in print semi-monthly and is distributed electronically through the following vendors:

* Cambridge Scientific Abstracts
* DataStar
* Dialog
* DIMDI
* EBSCO
* Optionline div.PTI
* OVID
* SilverPlatter
* STN

Features:

IPA adds approximately 18,000 records annually and draws from a global selection of health care journals. The following methods of indexing are applied to each record:

* IPA Thesaurus - A unique index of terms for pharmacy-related concepts
* MeSH Terms - NLM index used in MEDLINE
* AHFS Therapeutic Classification System - Used in ASHP's Drug Info database
* Drug Trade Names - IPA index of trade names
* United States Adopted Names - Index of generic drug names
* CAS Registry Numbers - Unique chemical entity identifiers
* IPA Natural Products Index - Links common plant names to scientific names

IPA covers international literature in applied pharmacology. Each IPA record is accompanied by an English-language abstract produced by a four-person multi-lingual in-house editorial staff or outsourced translators. IPA has digitized backfiles to 1964 and offers the backfile as part of its subscriptions.

http://scientific.thomsonreuters.com/products/ipa/

Oral Surgery

Oral Surgery

Published in association with the British Association of Oral Surgeons

New journal from February 2008 (Vol. 1 Issue 1 Page 1-57) Free content


http://www.blackwell-synergy.com/loi/ors

Influenza and Other Respiratory Viruses

Influenza and Other Respiratory Viruses
6 issues per year.

2008

1. March 2008 (Vol. 2 Issue 2 Page 41-79) Free content
2. January 2008 (Vol. 2 Issue 1 Page 1-40) Free content

2007
1. September/November 2007 (Vol. 1 Issue 5-6 Page 177-221) Free content
2. July 2007 (Vol. 1 Issue 4 Page 131-175) Free content
3. May 2007 (Vol. 1 Issue 3 Page 81-129) Free content
4. March 2007 (Vol. 1 Issue 2 Page 41-79) Online Open Free content
5. January 2007 (Vol. 1 Issue 1 Page 1-40) Free content


http://www.blackwell-synergy.com/loi/irv

The Clinical Respiratory Journal

The Clinical Respiratory Journal

The Official Journal of The Nordic Respiratory Academy
2 issues per year.

2008 free

1. April 2008 (Vol. 2 Issue 2 Page 65-129) Free content
2. January 2008 (Vol. 2 Issue 1 Page 1-64) Free content

2007 free

1. December 2007 (Vol. 1 Issue 2 Page 61-129) Free content
2. July 2007 (Vol. 1 Issue 1 Page 1-59) Free content

Get it from here:
http://www.blackwell-synergy.com/loi/crj

World Journal of Urology

World Journal of Urology
ISSN 0724-4983 (Print) 1433-8726 (Online)

From Full access to content
Number 1 / April, 1983 to Number 2 / April, 2008

Techniques in Coloproctology

Techniques in Coloproctology
ISSN 1123-6337 (Print) 1128-045X (Online)
From Number 1 / June, 1999 to Number 4 / December, 2007 (3 issues / year)

http://www.springerlink.com/content/1123-6337

Oral and Maxillofacial Surgery

Oral and Maxillofacial Surgery
Number 1 / May, 2008

Prior to Tuesday, January 01, 2008 this journal was named Mund-, Kiefer- und Gesichtschirurgie

http://www.springerlink.com/content/121011/

Obesity Surgery

Obesity Surgery
ISSN 0960-8923 (Print) 1708-0428 (Online)

From Number 1 / March, 1991 to Number 6 / June, 2008

http://springerlink.com/content/120415/

Langenbeck's Archives of Surgery

Langenbeck's Archives of Surgery
ISSN 1435-2443 (Print) 1435-2451 (Online)
From Number 1 / March, 1872 to Number 4 / July, 2008 (136 years)

http://www.springerlink.com/content/1435-2443

La radiologia medica

La radiologia medica
ISSN 0033-8362 (Print) 1826-6983 (Online)

From Number 1 / February, 2006 to Number 3 / April, 2008

http://www.springerlink.com/content/0033-8362

Journal of Robotic Surgery

Journal of Robotic Surgery
ISSN 1863-2483 (Print) 1863-2491 (Online)
Number 1 / March, 2007 to Number 1 / May, 2008


http://www.springerlink.com/content/1863-2483

The Journal of Headache and Pain

The Journal of Headache and Pain
ISSN 1129-2369 (Print) 1129-2377 (Online)

Volume 9, Number 1 / February, 2008
and Selected articles from other issues

http://www.springerlink.com/content/1129-2369

Journal of Digital Imaging

Journal of Digital Imaging
ISSN 0897-1889 (Print) 1618-727X (Online)
From Number 1 / March, 2002 to Number 2 / June, 2008

http://www.springerlink.com/content/0897-1889

International Journal of Colorectal Disease

International Journal of Colorectal Disease
ISSN 0179-1958 (Print) 1432-1262 (Online)

from Number 1 / March, 1986 to Number 7 / July, 2008

http://www.springerlink.com/content/0179-1958

Diseases of the Colon & Rectum

Diseases of the Colon & Rectum
ISSN 0012-3706 (Print) 1530-0358 (Online)
From Number 1 / January, 1958 to Number 5 / May, 2008

http://www.springerlink.com/content/0012-3706

Annals of Surgical Oncology

Annals of Surgical Oncology
ISSN 1068-9265 (Print) 1534-4681 (Online)

from Number 1 / January, 1994 to No.6 Volume 15 June 2008

http://www.springerlink.com/content/1068-9265

Free treatment

Those with rare diseases offered a chance for free treatment

They're the cold cases of medicine, patients with diseases so rare and mysterious that they've eluded diagnosis for years.

The National Institutes of Health is seeking those patients — and ones who qualify could get some free care at the government's top research hospital as scientists study why they're sick.

"These patients are to a certain extent abandoned by the medical profession because a brick wall has been hit," said Dr. William Gahl, who helped develop the NIH's new Undiagnosed Diseases Program. "We're trying to remove some of that."

The pilot program, announced Monday, can only recruit about 100 patients a year. But federal health officials hope that unraveling some of these super-rare diseases in turn will provide clues to more common illnesses.

"We believe this is not only a service to be rendered, but also knowledge to be gained," said NIH Director Dr. Elias Zerhouni.

About 10,000 new patients a year sign up for roughly 1,500 different research studies, many of them for rare diseases, at the NIH's Bethesda, Md., hospital, the innocuously named Clinical Center.

The new mystery-disease program is aimed at people with the rarest of the rare diseases — even those with truly brand-new ailments — who otherwise would be turned away because there are no studies, yet, for their conditions or a researcher specifically tracking their symptoms. It doesn't promise a diagnosis, but the chance to be reevaluated by a team of renowned specialists.

Amanda Young of Conyers, Ga., illustrates patient frustration. By age 3 1/2, she had suffered repeated lifethreatening infections that left doctor after doctor baffled. At 8, a scratch turned gangrenous, requiring her leg to be amputated. Yet under the microscope, her immune system seemed normal except for an unexplained low white blood cell count.

In 1990, not long after that amputation, her desperate parents brought her to NIH, where the hospital director "made us a promise," Young recalled. "He told us he would never give up on me."

It took until 2003, but Young got a phone call: "My disease finally had a name."

Gene research had uncovered a previously unknown immune-system pathway — showing NIH's Dr. John Gallin that Young harbors an extremely rare mutation, named IRAK4 deficiency, that means she lacks a protein key for that pathway to work.

There's no treatment yet. But Young, now 26, continues to volunteer for research in hopes of one.

To be considered for the new program, a doctor must refer a mystery patient to the NIH and send all medical files for evaluation. Accepted patients will undergo up to a week's additional testing at the Clinical Center, for free.

For more information, see http://rarediseases.info.nih.gov/undiagnosed

Source: YahooNews

Google makes health service publicly available

Google makes health service publicly available

Checkout details here:

http://www.google.com/health

Abortion [Video Training]

Abortion [Video Training]
18354 KB
This a video showing the abortion procedure done in a hospital. Its not a lecture

WMV file format

http://rapidshare.com/files/112424681/Abortion_Video.wmv
or
http://ifile.it/ci3u015

Mayo Clinic proceedings

Mayo Clinic proceedings

A peer-reviewed medical journal. Articles older than 6 months are available free for all

http://www.mayoclinicproceedings.com/default.asp

FDA warns of fetal risk of two transplant drugs

FDA warns of fetal risk of two transplant drugs

U.S. health officials issued an alert on Friday about the risk of first-trimester miscarriages and birth defects from Novartis AG and Roche Holding AG transplant drugs.

A strong warning about those risks was added to the labels of Roche's CellCept and Novartis' Myfortic in November.

The new alert was meant, in part, to grab the attention of doctors who prescribe the drugs for unapproved uses such as treating lupus, said Food and Drug Administration spokesman Christopher Kelly.

The FDA alert also was issued as a reminder to doctors who prescribe the immune-suppressing drugs for the approved use of preventing rejection of transplanted organs, Kelly said.

Roche spokesman Christopher Vancheri said the company had sent a letter to doctors when the "black box" warning, the strongest type for prescription drugs, was added last year.

The FDA's Kelly said some physicians who prescribe the drugs for unapproved uses may not have noticed the labeling change or the letter from manufacturers.

Reported birth defects included cleft lip and palate, and ear deformities, the FDA said.

Data from a U.S. pregnancy registry showed 15 miscarriages and four birth defects among 33 pregnancies with exposure to CellCept, Vancheri said. Data is reported voluntarily so the rates of problems cannot be precisely calculated.

Also, because many transplant patients take a combination of immune-suppressing drugs, "it is not possible to determine whether causality or not can be attributed to CellCept," Vancheri added.

Novartis spokeswoman Amy Hunter said the company had not received any reports of birth defects associated with Myfortic, known generically as mycophenolic acid, at the time of the label change in November.

The drugmaker added the warning, however, at the FDA's request, she said. Myfortic is chemically similar to CellCept, known generically as mycophenolate mofetil.

In April, the FDA said it was investigating if CellCept and Myfortic may trigger a potentially fatal brain disorder called progressive multifocal leukoencephalopathy. That review is ongoing.

Sourece reuters